Skip to main content
. 2022 Oct 3;12(10):e064166. doi: 10.1136/bmjopen-2022-064166

Table 2.

Summary of data collection

Assessment Screening Day 1 baseline Phase 1 Day 31 baseline Phase 2 Study exit
Assessment of eligibility criteria Once Once
Written informed consent Once
Demographic data, contact details Once
Weight/height Once
Known triggers Once
Peak flow Twice daily
Heart rate Automated
Activity Automated
Location, air quality and allergens Daily
Inhaler usage Daily and weekly Automated
Symptoms Daily and weekly Daily
Triggers encountered Daily Daily
Healthcare usage Weekly Weekly
Feedback Once at the end